In March 2025, Hypervision Surgical had the distinct honour of presenting its groundbreaking HYPERSNAP® Surgical System to Her Royal Highness The Princess Royal during her official visit to King’s College London. The occasion underscored the vital role of next-generation medical technologies in advancing surgical care and improving patient outcomes.
A spin-out from King’s College London, Hypervision Surgical is pioneering the integration of hyperspectral imaging and artificial intelligence to enhance intraoperative decision-making. Its flagship product, the HYPERSNAP® Surgical System – recently awarded UK Conformity Assessed (UKCA) marking – represents a major advancement in surgical visualisation. By providing real-time, dye-free tissue oxygenation maps alongside standard white-light imaging, HYPERSNAP® enables surgeons to see beyond the visible, supporting safer, more precise interventions.
Dr Michael Ebner, CEO of Hypervision Surgical, presents the HYPERSNAP® Surgical System to Her Royal Highness The Princess Royal during her visit to King’s College London.
During her visit, The Princess Royal engaged with researchers and clinicians at King’s to explore how science and technology are being harnessed to tackle global healthcare challenges. The presentation of Hypervision Surgical’s work showcased the tangible impact of academic innovation translated into a commercial medical device for patient and public benefit.
Hypervision Surgical’s participation in this event reflects its commitment to revolutionising surgical practice through cutting-edge innovation. The opportunity to demonstrate its technology to Her Royal Highness stands as a proud milestone in the company’s journey, and a testament to its mission to enhance surgical care and patient safety on a global scale.